| 1 | Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Ng · 2017 · Lancet | | 4,850 |
| 2 | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Jostins · 2012 · Nature | | 3,772 |
| 3 | Ulcerative colitis. Ungaro · 2017 · Lancet | | 2,933 |
| 4 | Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Silverberg MS · 2005 · Can J Gastroenterol | | 2,706 |
| 5 | Inflammatory bowel disease. Abraham · 2009 · N Engl J Med | | 2,295 |
| 6 | Infliximab for the treatment of fistulas in patients with Crohn's disease. Present DH · 1999 · N Engl J Med | | 2,140 |
| 7 | The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Dougados · 1991 · Arthritis Rheum | | 1,928 |
| 8 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Lamb · 2019 · Gut | | 1,855 |
| 9 | IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Grivennikov S · 2009 · Cancer Cell | | 1,833 |
| 10 | Ulcerative colitis Ordás · 2012 · Lancet | | 1,764 |
| 11 | Infliximab maintenance therapy for fistulizing Crohn's disease. Sands BE · 2004 · N Engl J Med | | 1,723 |
| 12 | Epidemiology and natural history of inflammatory bowel diseases. Cosnes · 2011 · Gastroenterology | | 1,669 |
| 13 | Crohn's disease. Baumgart · 2012 · Lancet | | 1,636 |
| 14 | Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Riddell · 1983 · Hum Pathol | | 1,595 |
| 15 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management. Gomollón F · 2017 · J Crohns Colitis | | 1,579 |
| 16 | TNF-mediated inflammatory disease. Bradley · 2008 · J Pathol | | 1,540 |
| 17 | Predictability of the postoperative course of Crohn's disease. Rutgeerts P · 1990 · Gastroenterology | | 1,465 |
| 18 | Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders Magro · 2017 · J Crohns Colitis | | 1,458 |
| 19 | Inflammatory bowel disease: clinical aspects and established and evolving therapies Baumgart · 2007 · Lancet | | 1,447 |
| 20 | Ulcerative colitis and colorectal cancer. A population-based study. Ekbom · 1990 · N Engl J Med | | 1,444 |
| 21 | Cyclosporine in severe ulcerative colitis refractory to steroid therapy. Lichtiger · 1994 · N Engl J Med | | 1,439 |
| 22 | Microbial influences in inflammatory bowel diseases Sartor · 2008 · Gastroenterology | | 1,433 |
| 23 | Ulcerative colitis Kobayashi · 2020 · Nat Rev Dis Primers | | 1,391 |
| 24 | Therapeutic roles of curcumin: lessons learned from clinical trials. Gupta · 2013 · AAPS J | | 1,287 |
| 25 | Ulcerative colitis. Le Berre Catherine · 2023 · Lancet | | 1,280 |
| 26 | The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Rudwaleit · 2011 · Ann Rheum Dis | | 1,249 |
| 27 | Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Tracey · 2008 · Pharmacol Ther | | 1,234 |
| 28 | ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. Levine A · 2014 · J Pediatr Gastroenterol Nutr | | 1,124 |
| 29 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. Dignass · 2010 · J Crohns Colitis | | 1,107 |
| 30 | ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. Torres J · 2020 · J Crohns Colitis | | 1,106 |
| 31 | Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Anderson CA · 2011 · Nat Genet | | 1,079 |
| 32 | The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Greenstein · 1976 · Medicine (Baltimore) | | 1,063 |
| 33 | Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee Kornbluth · 2010 · Am J Gastroenterol | | 1,044 |
| 34 | Proctocolectomy without ileostomy for ulcerative colitis. Parks A · 1978 · Br Med J | | 1,030 |
| 35 | Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Itzkowitz SH · 2004 · Am J Physiol Gastrointest Liver Physiol | | 1,024 |
| 36 | Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial Gionchetti · 2000 · Gastroenterology | | 1,022 |
| 37 | Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Rutter · 2004 · Gastroenterology | | 980 |
| 38 | Development and validation of a pediatric Crohn's disease activity index. Hyams · 1991 · J Pediatr Gastroenterol Nutr | | 965 |
| 39 | Ileal pouch-anal anastomoses complications and function in 1005 patients Fazio · 1995 · Ann Surg | | 961 |
| 40 | A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Gasche · 2000 · Inflamm Bowel Dis | | 957 |
| 41 | Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Harbord · 2017 · J Crohns Colitis | | 942 |
| 42 | Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Shi Y · 2018 · Nat Rev Nephrol | | 941 |
| 43 | Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Frøslie · 2007 · Gastroenterology | | 938 |
| 44 | Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Buonocore · 2010 · Nature | | 924 |
| 45 | Intestinal inflammation and cancer. Ullman TA · 2011 · Gastroenterology | | 920 |
| 46 | Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Beaugerie L · 2009 · Lancet | | 895 |
| 47 | The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. Taurog · 1994 · J Exp Med | | 889 |
| 48 | Diagnosis and management of primary sclerosing cholangitis. Chapman · 2010 · Hepatology | | 880 |
| 49 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. Van Assche · 2010 · J Crohns Colitis | | 857 |
| 50 | Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Jurenka · 2009 · Altern Med Rev | | 839 |
| 51 | Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Järnerot · 2005 · Gastroenterology | | 836 |
| 52 | The natural history of adult Crohn's disease in population-based cohorts. Peyrin-Biroulet L · 2010 · Am J Gastroenterol | | 832 |
| 53 | Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Panés J · 2016 · Lancet | | 828 |
| 54 | Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Ruemmele FM · 2014 · J Crohns Colitis | | 819 |
| 55 | European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Zouboulis · 2015 · J Eur Acad Dermatol Venereol | | 812 |
| 56 | Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. Baeten · 2015 · N Engl J Med | | 811 |
| 57 | ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ramiro · 2023 · Ann Rheum Dis | | 811 |
| 58 | The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Schwartz DA · 2002 · Gastroenterology | | 810 |
| 59 | CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Lesage · 2002 · Am J Hum Genet | | 796 |
| 60 | Guidelines for the management of inflammatory bowel disease in adults. Carter · 2004 · Gut | | 793 |
| 61 | Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Akdis · 2021 · Nat Rev Immunol | | 782 |
| 62 | Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Colombel · 2011 · Gastroenterology | | 770 |
| 63 | Reduced Paneth cell alpha-defensins in ileal Crohn's disease Wehkamp · 2005 · Proc Natl Acad Sci U S A | | 769 |
| 64 | Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Madsen · 2001 · Gastroenterology | | 764 |
| 65 | Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Popivanova BK · 2008 · J Clin Invest | | 759 |
| 66 | Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics Sartor · 2004 · Gastroenterology | | 759 |
| 67 | Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial Gionchetti · 2003 · Gastroenterology | | 751 |
| 68 | CARD15 mutations in Blau syndrome. Miceli-Richard · 2001 · Nat Genet | | 750 |
| 69 | Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Van Limbergen J · 2008 · Gastroenterology | | 746 |
| 70 | Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Chapman RW · 1980 · Gut | | 741 |
| 71 | Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Jess · 2012 · Clin Gastroenterol Hepatol | | 737 |
| 72 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management Dignass · 2012 · J Crohns Colitis | | 736 |
| 73 | Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Endo · 2008 · Ann Surg | | 727 |
| 74 | Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Lichtenstein GR · 2006 · Clin Gastroenterol Hepatol | | 721 |
| 75 | Predictors of Crohn's disease. Beaugerie L · 2006 · Gastroenterology | | 720 |
| 76 | Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Zhang M · 2016 · Biomaterials | | 718 |
| 77 | Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Frolkis · 2013 · Gastroenterology | | 716 |
| 78 | Risk factors for cholangiocarcinoma. Tyson · 2011 · Hepatology | | 716 |
| 79 | Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. 2013 · Nat Genet | | 711 |
| 80 | Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Darfeuille-Michaud A · 1998 · Gastroenterology | | 693 |
| 81 | Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Shah SC · 2022 · Gastroenterology | | 685 |
| 82 | Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. D'Haens · 1998 · Gastroenterology | | 684 |
| 83 | Primary sclerosing cholangitis - a comprehensive review. Karlsen · 2017 · J Hepatol | | 684 |
| 84 | Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation Sinha · 2020 · Cell Host Microbe | | 681 |
| 85 | Management of Crohn's disease in adults. Lichtenstein GR · 2009 · Am J Gastroenterol | | 680 |
| 86 | Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Rogler · 2021 · Gastroenterology | | 675 |
| 87 | Mesenchymal stem cells: mechanisms of inflammation. Singer NG · 2011 · Annu Rev Pathol | | 661 |
| 88 | Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Ng SC · 2013 · Gastroenterology | | 653 |
| 89 | Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Kiesslich R · 2003 · Gastroenterology | | 650 |
| 90 | Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Thia KT · 2010 · Gastroenterology | | 641 |
| 91 | Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Rutgeerts P · 1984 · Gut | | 640 |
| 92 | Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Feldtkeller · 2003 · Rheumatol Int | | 640 |
| 93 | Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches Sartor · 2017 · Gastroenterology | | 640 |
| 94 | Spondyloarthritis. Dougados · 2011 · Lancet | | 637 |
| 95 | Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gupta RB · 2007 · Gastroenterology | | 629 |
| 96 | Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Cohen · 2007 · Orphanet J Rare Dis | | 620 |
| 97 | European evidence based consensus for endoscopy in inflammatory bowel disease. Annese Vito · 2013 · J Crohns Colitis | | 617 |
| 98 | Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Mimura · 2004 · Gut | | 616 |
| 99 | Predicting outcome in severe ulcerative colitis. Travis · 1996 · Gut | | 613 |
| 100 | Behçet's disease. Report of 41 cases and a review of the literature. Chajek · 1975 · Medicine (Baltimore) | | 609 |